May 1997
|
Donepezil first recorded in CPRD
|
September 1998
|
Rivastigmine first recorded in CPRD
|
January 2001
|
Galantamine first recorded in CPRD and first NICE guidance released
|
December 2002
|
Memantine first recorded in CPRD
|
November 2006
|
NICE recommended restricting drug access
|
September 2007
|
QOF revised to include dementia
|
February 2009
|
First National Dementia Strategy launched
|
March 2011
|
NICE removed recommendation restricting drug access
|
January 2012
|
Galantamine patent expired
|
February 2012
|
Donepezil patent expired
|
May 2012
|
Prime Minister’s Dementia Challenge launched
|
July 2012
|
Rivastigmine patent expired
|
April 2014
|
Memantine patent expired
|
February 2015
|
Prime Minister’s Challenge on Dementia 2020 launched
|